five

HMGB2 in endocrine resistant breast cancer. HMGB2 in endocrine resistant breast cancer

收藏
NIAID Data Ecosystem2026-03-09 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJEB4550
下载链接
链接失效反馈
官方服务:
资源简介:
HMGB2 and ER ChIPseq was investigated in the MCF-7 endocrine sensitive and LY2 endocrine resistant cell lines upon treatment with Tamoxifen.
创建时间:
2014-10-22
二维码
社区交流群
二维码
科研交流群
商业服务